One out of every six pregnancies experience pre-eclampsia, for which the only effective therapy is delivery of the baby.

Our patented NO technology has been shown to reduce systemic blood pressure in pre-eclampsia patients without an increase in intracranial pressure. Ongoing trials at Baylor College of Medicine suggest that treatment with NO may normalize blood pressure and extend gestation to full-term.